Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?

To: kech who wrote (708818)	3/28/2020 8:02:59 PM
From: kech	16 Recommendations Recommended By Alan Smithee alanrs burlegoat garrettjax locogringo and 11 more members Read Replies (1) \| Respond to of 793958

Some additional comments from the doctor who is doing the trial of HCL and Zpac (and zinc) and was interviewed by Giulani. He thinks the HCL acts as a bridge to open access to the cell and then the zinc can do more to disrupt the production of the virus. The Zpac is more to reduce inflamation of lungs and prevent the critical phase. He points out the treatment does not reduce the symptoms but does prevent the disease from advancing. He commented at the end that many doctors he knows are getting on board with this treatment. He thinks this is really the solution to the problem because it keeps people out of the need for critical care if used early. He points out that if the disease progresses to the point that ventilators are needed it is a disaster because the state of the lungs at that point have gone into a whole different state of failure from which there is no good return. He gave treatment to people once they were having trouble breathing, so he did not give treatment to people with minor symptoms, but he also did not wait until they were in a crisis. Also he points out the great thing about this treatment is that the pills cost a total of $20 for the 5 day treatment and they are widely available and side effects are well known. In terms of side effects, he says if there is a 1 in 10,000 chance of cardiac arythmia vs a 6% chance of dying for someone with strong initial symptoms, then it is a no brainer to take the treatment.

To: kech who wrote (708818)	3/29/2020 9:06:36 AM
From: Stevefoder	4 Recommendations Recommended By Mevis pak73 Stan Tom Clarke Read Replies (2) \| Respond to of 793958

*Could take awhile to get results from the trials since they are double blind* There comes a point during such tests, that it can become so obvious that a treatment works that it becomes immoral to keep the control group untreated. That happened during trials of a heart attack emergency med. Some were untreated and others treated with the new medication. It became obvious early on that the new medication worked so they stopped the experimentation saying that it was wrong to have the control group remain untreated. The heart med experience was about 20 years ago.